Lasam, Arnold .
HRN: 00-18-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/06/2025
05/13/2025
IV
500mg
Q8
S/p Exlap-ap Lavage
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes